Claims
- 1. A 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI.sub.2 derivative having the formula: ##STR189## (wherein R.sub.2 represents hydrogen atom, a pharmaceutically acceptable cation or an ester residue selected from the group consisting of
- (i) a normal alkyl group having 1 to 12 carbon atoms or a branched alkyl group having 3 to 12 carbon atoms;
- (ii) --Z--R.sub.5 (wherein Z represents a valence bond or a normal or branched alkylene group defined as the formula C.sub.t H.sub.2t (t is an integer of 1 to 5 and R.sub.5 represents a cycloalkyl group with 3 to 12 ring members which is unsubstituted or substituted by 1 to 4 normal alkyl substituents containing 1 to 4 carbon atoms), wherein R.sub.2 and R.sub.4 represented by the same formula may be the same or different;
- (iii) --Z--Ar (wherein Z has the same meaning as in (ii) and Ar represents a phenyl group unsubstituted or substituted by 1 to 4 substituents selected from the group consisting of alkyl, methoxy, chloro, bromo, fluoro, iodo, trifluoromethyl, nitro, cyano, phenyl and phenoxy);
- (iv) --(CH.sub.2 CH.sub.2 O).sub.n --CH.sub.3 (wherein n is an integer of 1 to 5);
- (v) --Z--R.sub.7 (wherein Z has the same meaning as in (ii), R.sub.7 represents .alpha.-naphthyl group, .beta.-naphthyl group, 2-pyridyl group, 3-pyridyl group, 4-pyridyl group, .alpha.-furyl group, .beta.-furyl group, .alpha.-thienyl group or .beta.-thienyl group);
- (vi) --C.sub.t H.sub.2t COOR.sub.8 (wherein C.sub.t H.sub.2t has the same meaning as in (ii); R.sub.8 represents methyl group, ethyl group or propyl group) or ##STR190## (wherein R.sub.9 represents hydrogen atom or benzoyl group; R.sub.10 represents phenyl group, p-bromophenyl group, p-chlorophenyl group, p-biphenyl group, p-nitrophenyl group, p-benzamidophenyl group or 2-naphthyl group); and R.sub.4 represents
- (i) a normal alkyl group having 1 to 12 carbon atoms, or
- (ii) --Z--Ar (wherein Z represents a valance-bond or a normal or branched alkylene group defined as C.sub.t H.sub.2t (wherein t is an integer of 1 to 5); Ar represents a phenyl group which is unsubstituted or substituted by 1 to 4 substituents selected from the group consisting of alkyl, methoxy, chloro, bromo, fluoro, iodo, trifluoromethyl, nitro, cyano, phenyl and phenoxy), or
- (iii) --Z--R.sub.5 (wherein Z has the same meaning as in (ii); R.sub.5 represents a cycloalkyl alkyl substituents containing 1 to 4 carbon atoms).
- 2. The PGI.sub.2 derivative as claimed in claim 1 which is selected from the group consisting of 15-phenyl-2,5,6,7,16,17,18,19,20-nonanor-4,8-inter-m-phenylene PGI.sub.2, 16-methyl-17-phenyl-2,5,6,7,18,19,20-heptanor-4,8-inter-m-phenylene PGI.sub.2 and 16,16-dimethyl-17-phenyl-2,5,6,7,18,19,20-heptanor-4,8-inter-m-phenylene PGI.sub.2.
- 3. A pharmaceutical composition comprising PGI.sub.2 derivative as claimed in claim 1.
- 4. The pharmaceutical composition as claimed in claim 3, which is used as antihypertensive drug.
- 5. The pharmaceutical composition as claimed in claim 3, which is used as treatment for ischemic cerebral disease.
- 6. The pharmaceutical composition as claimed in claim 3, which is used as treatment for myocardial infarction.
- 7. The pharmaceutical composition as claimed in claim 3, which is used as treatment for angina pectoris.
- 8. The pharmaceutical composition as claimed in claim 3, which is used as treatment for TIA.
- 9. The pharmaceutical composition as claimed in claim 3, which is used as treatment for peripheral circulation disturbance.
- 10. The pharmaceutical composition as claimed in claim 3, which is used as antiarteriosclerosis drug.
- 11. The pharmaceutical composition as claimed in claim 3, which is used as antithrombus drug.
- 12. The pharmaceutical composition as claimed in claim 3, which is used as antiulcer drug.
Priority Claims (1)
Number |
Date |
Country |
Kind |
62-262021 |
Oct 1987 |
JPX |
|
Parent Case Info
This application is a continuation of application Ser. No. 07/667,245, filed Mar. 8, 1991, now abandoned, which is a continuation of application Ser. No. 07/377,827, filed on Aug. 14, 1989, now abandoned.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/JP88/01048 |
10/14/1988 |
|
|
8/14/1989 |
8/14/1989 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO89/03387 |
4/20/1989 |
|
|
US Referenced Citations (2)
Foreign Referenced Citations (3)
Number |
Date |
Country |
274004 |
Jul 1988 |
EPX |
0274064 |
Jul 1988 |
EPX |
32277 |
Feb 1982 |
JPX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
377827 |
Aug 1989 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
667245 |
Mar 1991 |
|